Cargando…
Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
BACKGROUND: Ankylosing spondylitis (AS) is a chronic immune-mediated disease affecting the sacroiliac joints and the spine, manifesting with new bone formation and osteopenia. Five tumor necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab, and golimumab) are av...
Autores principales: | Ma, Zeren, Liu, Xiaoping, Xu, Xiaosheng, Jiang, Jie, Zhou, Jian, Wang, Jia, Chen, Dewang, Luo, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484196/ https://www.ncbi.nlm.nih.gov/pubmed/28640088 http://dx.doi.org/10.1097/MD.0000000000007145 |
Ejemplares similares
-
Concurrent Intervention With Exercises and Stabilized Tumor Necrosis Factor Inhibitor Therapy Reduced the Disease Activity in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liang, Hui, et al.
Publicado: (2015) -
The Role of MicroRNAS in Ankylosing Spondylitis
por: Li, Zheng, et al.
Publicado: (2016) -
Musculoskeletal ultrasound for ankylosing spondylitis: A systematic review and meta-analysis
por: Zhu, Lin, et al.
Publicado: (2021) -
Influence of kyphosis in ankylosing spondylitis on cardiopulmonary functions
por: Yang, Yunfei, et al.
Publicado: (2023) -
Identification of potential target genes for ankylosing spondylitis treatment
por: Ni, Yong, et al.
Publicado: (2018)